Therapeutic Response of Ayurvedic Preparation Raj Nirwan Bati on Severe COVID-19 Patients: A Double-Blind Randomized Placebo Controlled Clinical Trial

Raj Kumar; Ramakant Yadav; Usha Shukla; Naresh Pal Singh; Sushil Kumar Yadav; Sushil Kumar Shukla; Manoj Kumar; Amit Singh

doi:10.5455/AAM.88853

2024, Vol: 13, Issue: 3

13 / 3Current Issue Online First Archive Aims and Scope Abstracting & Indexing Most Accessed Articles Most Downloaded Articles Most Cited Articles

Required files to be uploaded

Cover letter

« Previous Article

Original Research

AAM. 2021; 10(3): 231-243

doi: 10.5455/AAM.88853

Therapeutic Response of Ayurvedic Preparation Raj Nirwan Bati on Severe COVID-19 Patients: A Double-Blind Randomized Placebo Controlled Clinical Trial

Raj Kumar, Ramakant Yadav, Usha Shukla, Naresh Pal Singh, Sushil Kumar Yadav, Sushil Kumar Shukla, Manoj Kumar, Amit Singh.

Abstract
Background: The burden of present pandemic of COVID-19 is increasing exponentially day by day. There is a felt need for
research on various treatment options available in the indigenous system of medicine. Ayurvedic (Indian system of medicine)
preparations have been proven previously to be effective in many viral illnesses and play an important role in boosting the
immunity of the human body.
Aim and Objectives: To evaluate the therapeutic response of ayurvedic preparation RNB on severe COVID-19 patients.
Methodology: A double-blind randomized placebo controlled clinical trial was conducted on 49 severely ill patients of COVID- 19 with one arm receiving RNB and the other placebo. Patients were evaluated on day-to-day basis and clinical improvement was assessed by a two-point reduction in patients admission status on a six-point ordinal scale.
Results: Statistically significant (p=0.003) difference in proportion of conversion of Real Time Polymerase Chain Reaction (RT-PCR) result after six days of intervention was observed in both groups. The mean ± SD days required for the patients to become negative by RT-PCR test was shorter in RNB compared (10.1 ± 4.1 days) versus 14.4 ± 5.9 days in control group of patients and was found to be statistically significant (p=0.012). Average days to achieve two-point improvement on sixpoint
clinical improvement ordinal scale was shorter in RNB group in comparison to placebo control group (7.9 ± 4.1 days versus 11.7 ± 4.7, p=0.009). The duration of hospital-stay and oxygen therapy required for management of COVID-19 cases was shorter in RNB intervention patients than in control group.
Conclusion: Immunomodulatory, anti-inflammatory, anti-viral and broncho-dilatory properties in ayurvedic formulation makes RNB an ideal drug to act as an adjuvant to standard allopathic treatment against COVID-19 illness even in severely and critically ill patients in the present scenario.

Key words: COVID-19, Ayurvedic medicine, SARS-CoV-2, RT-PCR

	ARTICLE TOOLS
	Abstract
	PDF Fulltext
	How to cite this article
	Citation Tools
	Related Records
	Articles by Raj Kumar Articles by Ramakant Yadav Articles by Usha Shukla Articles by Naresh Pal Singh Articles by Sushil Kumar Yadav Articles by Sushil Kumar Shukla Articles by Manoj Kumar Articles by Amit Singh
	on Google
	on Google Scholar

How to Cite this Article

Pubmed Style

Kumar R, Yadav R, Shukla U, Singh NP, Yadav SK, Shukla SK, Kumar M, Singh A. Therapeutic Response of Ayurvedic Preparation Raj Nirwan Bati on Severe COVID-19 Patients: A Double-Blind Randomized Placebo Controlled Clinical Trial. AAM. 2021; 10(3): 231-243. doi:10.5455/AAM.88853

Web Style

Kumar R, Yadav R, Shukla U, Singh NP, Yadav SK, Shukla SK, Kumar M, Singh A. Therapeutic Response of Ayurvedic Preparation Raj Nirwan Bati on Severe COVID-19 Patients: A Double-Blind Randomized Placebo Controlled Clinical Trial. https://www.aamjournal.in/?mno=88853 [Access: September 12, 2024]. doi:10.5455/AAM.88853

AMA (American Medical Association) Style

Kumar R, Yadav R, Shukla U, Singh NP, Yadav SK, Shukla SK, Kumar M, Singh A. Therapeutic Response of Ayurvedic Preparation Raj Nirwan Bati on Severe COVID-19 Patients: A Double-Blind Randomized Placebo Controlled Clinical Trial. AAM. 2021; 10(3): 231-243. doi:10.5455/AAM.88853

Vancouver/ICMJE Style

Harvard Style

Kumar, R., Yadav, . R., Shukla, . U., Singh, . N. P., Yadav, . S. K., Shukla, . S. K., Kumar, . M. & Singh, . A. (2021) Therapeutic Response of Ayurvedic Preparation Raj Nirwan Bati on Severe COVID-19 Patients: A Double-Blind Randomized Placebo Controlled Clinical Trial. AAM, 10 (3), 231-243. doi:10.5455/AAM.88853

Turabian Style

Kumar, Raj, Ramakant Yadav, Usha Shukla, Naresh Pal Singh, Sushil Kumar Yadav, Sushil Kumar Shukla, Manoj Kumar, and Amit Singh. 2021. Therapeutic Response of Ayurvedic Preparation Raj Nirwan Bati on Severe COVID-19 Patients: A Double-Blind Randomized Placebo Controlled Clinical Trial. Annals of Ayurvedic Medicine, 10 (3), 231-243. doi:10.5455/AAM.88853

Chicago Style

Kumar, Raj, Ramakant Yadav, Usha Shukla, Naresh Pal Singh, Sushil Kumar Yadav, Sushil Kumar Shukla, Manoj Kumar, and Amit Singh. "Therapeutic Response of Ayurvedic Preparation Raj Nirwan Bati on Severe COVID-19 Patients: A Double-Blind Randomized Placebo Controlled Clinical Trial." Annals of Ayurvedic Medicine 10 (2021), 231-243. doi:10.5455/AAM.88853

MLA (The Modern Language Association) Style

APA (American Psychological Association) Style

About Annals of Ayurvedic Medicine

Contact Information

How to cite this article


About Annals of Ayurvedic Medicine Annals of Ayurvedic Medicine (AAM) is the organ of ‘Association of Ayurvedic Physicians of India'(AAPI), which is a national representative body of Ayur ... Read more. For best results, please use Internet Explorer or Google Chrome.	Contact Information Editorial Office : Prof Sanjeev Rastogi Vatsala Hospital, Tulsi Das Marg, Lucknow-226003, INDIA Main Office : 6, Ganga Bag Colony, Lanka, Varanasi -221005, INDIA Editorial Contact: Email: rastogisanjeev@rediffmail.com Mobile: 0091-9415022955